<code id='39811D572A'></code><style id='39811D572A'></style>
    • <acronym id='39811D572A'></acronym>
      <center id='39811D572A'><center id='39811D572A'><tfoot id='39811D572A'></tfoot></center><abbr id='39811D572A'><dir id='39811D572A'><tfoot id='39811D572A'></tfoot><noframes id='39811D572A'>

    • <optgroup id='39811D572A'><strike id='39811D572A'><sup id='39811D572A'></sup></strike><code id='39811D572A'></code></optgroup>
        1. <b id='39811D572A'><label id='39811D572A'><select id='39811D572A'><dt id='39811D572A'><span id='39811D572A'></span></dt></select></label></b><u id='39811D572A'></u>
          <i id='39811D572A'><strike id='39811D572A'><tt id='39811D572A'><pre id='39811D572A'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:leisure time    Page View:17945

          Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET.

          Relive this year’s J.P. Morgan Healthcare Conference with the STAT reporters who attended. Get a full rundown of the deals, data, and scuttlebutt and come away with the ideas and water-cooler chatter you need for the year ahead.

          advertisement

          Sponsor introduction

          • John Arena, SVP, enterprise strategy & solutions, Cencora

          Featured speakers

          • Tara Bannow, hospitals and insurance reporter, STAT
          • Damian Garde, national biotech reporter, STAT
          • Matthew Herper, senior writer, medicine; editorial director of events, STAT
          • Allison DeAngelis, biotech startups and venture capital reporter, STAT (moderator)

          Sponsored By

          Cencora

          leisure time

          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more
          Roivant's CEO is a star, but biotech's black hole persists
          Roivant's CEO is a star, but biotech's black hole persists

          MollyFerguson/STATRoivantSciences’MattGlinemightbethisyear’sbestbiopharmaCEO,andotherthoughtsaboutMo

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          Physician assistants need a new name. Here's what it should be

          AdobeI’mstandingoveranoperatingtable,excisingaskincancerfromtheforeheadofanelderlygentlemanwhilesoft